Literature DB >> 33280058

Evaluation of a Motion Correction Algorithm for C-Arm Computed Tomography Acquired During Transarterial Chemoembolization.

Lena S Becker1, Marcel Gutberlet1, Sabine K Maschke1, Thomas Werncke1, Cornelia L A Dewald1, Christian von Falck1, Arndt Vogel2, Roman Kloeckner3, Bernhard C Meyer1, Frank Wacker1, Jan B Hinrichs4.   

Abstract

PURPOSE: The aim of this retrospective study was to evaluate the feasibility of a motion correction 3D reconstruction prototype technique for C-arm computed tomography (CACT).
MATERIAL AND METHODS: We included 65 consecutive CACTs acquired during transarterial chemoembolization of 54 patients (47 m,7f; 67 ± 11.3 years). All original raw datasets (CACTOrg) underwent reconstruction with and without volume punching of high-contrast objects using a 3D image reconstruction software to compensate for motion (CACTMC_bone;CACTMC_no bone). Subsequently, the effect on image quality (IQ) was evaluated using objective (image sharpness metric) and subjective criteria. Subjective criteria were defined by vessel geometry, overall IQ, delineation of tumor feeders, the presence of foreign material-induced artifacts and need for additional imaging, assessed by two independent readers on a 3-(vessel geometry and overall IQ) or 2-point scale, respectively. Friedman rank-sum test and post hoc analysis in form of pairwise Wilcoxon signed-rank test were computed and inter-observer agreement analyzed using kappa test.
RESULTS: Objective IQ as defined by an image sharpness metric, increased from 273.5 ± 28 (CACTOrg) to 328.5 ± 55.1 (CACTMC_bone) and 331 ± 57.8 (CACTMC_no bone; all p < 0.0001). These results could largely be confirmed by the subjective analysis, which demonstrated predominantly good and moderate inter-observer agreement, with best agreement for CACTMC_no bone in all categories (e.g., vessel geometry: CACTOrg: κ = 0.51, CACTMC_bone: κ = 0.42, CACTMC_no bone: κ = 0.69).
CONCLUSION: The application of a motion correction algorithm was feasible for all data sets and led to an increase in both objective and subjective IQ parameters. LEVEL OF EVIDENCE: 3.

Entities:  

Keywords:  Angiography; C-arm computed tomography; Cone beam computed tomography; Motion correction; Transarterial chemoembolization

Year:  2020        PMID: 33280058      PMCID: PMC7987696          DOI: 10.1007/s00270-020-02729-6

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  30 in total

1.  Image quality assessment: from error visibility to structural similarity.

Authors:  Zhou Wang; Alan Conrad Bovik; Hamid Rahim Sheikh; Eero P Simoncelli
Journal:  IEEE Trans Image Process       Date:  2004-04       Impact factor: 10.856

2.  ECG-gated interventional cardiac reconstruction for non-periodic motion.

Authors:  Christopher Rohkohl; Günter Lauritsch; Lisa Biller; Joachim Hornegger
Journal:  Med Image Comput Comput Assist Interv       Date:  2010

3.  Image quality improvements in C-Arm CT (CACT) for liver oncology applications: preliminary study in rabbits.

Authors:  Vania Tacher; Nikhil Bhagat; Pramod V Rao; Mingde Lin; Dirk Schäfer; Niels Noordhoek; Peter Eshuis; Alessandro Radaelli; Eleni Liapi; Michael Grass; Jean-François Geschwind
Journal:  Minim Invasive Ther Allied Technol       Date:  2013-07-09       Impact factor: 2.442

4.  Utility of cone-beam CT imaging in prostatic artery embolization.

Authors:  Sandeep Bagla; Kenneth S Rholl; Keith M Sterling; Arletta van Breda; Dimitrios Papadouris; James M Cooper; Arina van Breda
Journal:  J Vasc Interv Radiol       Date:  2013-08-23       Impact factor: 3.464

5.  Cone-beam CT hepatic arteriography in chemoembolization for hepatocellular carcinoma: angiographic image quality and its determining factors.

Authors:  In Joon Lee; Jin Wook Chung; Yong Hu Yin; Hyo-Cheol Kim; Young Il Kim; Hwan Jun Jae; Jae Hyung Park
Journal:  J Vasc Interv Radiol       Date:  2014-06-10       Impact factor: 3.464

6.  Comparison of C-arm Computed Tomography and Digital Subtraction Angiography in Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Jan B Hinrichs; Steffen Marquardt; Christian von Falck; Marius M Hoeper; Karen M Olsson; Frank K Wacker; Bernhard C Meyer
Journal:  Cardiovasc Intervent Radiol       Date:  2015-04-01       Impact factor: 2.740

Review 7.  How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer.

Authors:  Vania Tacher; Alessandro Radaelli; MingDe Lin; Jean-François Geschwind
Journal:  Radiology       Date:  2015-02       Impact factor: 11.105

8.  Identification of small hepatocellular carcinoma and tumor-feeding branches with cone-beam CT guidance technology during transcatheter arterial chemoembolization.

Authors:  Shiro Miyayama; Masashi Yamashiro; Masahiro Hashimoto; Nanako Hashimoto; Masaya Ikuno; Kenichiro Okumura; Miki Yoshida; Osamu Matsui
Journal:  J Vasc Interv Radiol       Date:  2013-02-26       Impact factor: 3.464

9.  Tracking Navigation Imaging of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Using Three-Dimensional Cone-Beam CT Angiography.

Authors:  Yasunori Minami; Yukinobu Yagyu; Takamichi Murakami; Masatoshi Kudo
Journal:  Liver Cancer       Date:  2014-03       Impact factor: 11.740

10.  C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads.

Authors:  Roland Syha; Gerd Grözinger; Ulrich Grosse; Michael Maurer; Lars Zender; Marius Horger; Konstantin Nikolaou; Dominik Ketelsen
Journal:  Cancer Imaging       Date:  2015-12-29       Impact factor: 3.909

View more
  1 in total

1.  Effectuality study of a 3D motion correction algorithm in C-arm CTs of severely impaired image quality during transarterial chemoembolization.

Authors:  Bernhard C Meyer; Jan B Hinrichs; Lena S Becker; Cornelia L A Dewald; Christian von Falck; Thomas Werncke; Sabine K Maschke; Roman Kloeckner; Frank K Wacker
Journal:  Cancer Imaging       Date:  2022-07-30       Impact factor: 5.605

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.